ScottBenjaminSchneiderMD

PubMed

• 9 citations
  The prognostic value of PSA levels in radiation therapy of patients with carcinoma of the prostate: the UCLA experience 1988-1992.
  Scott B. Schneider, Victor G. Schweitzer, Robert G. Parker, Paul W. Bycott> ;American Journal of Clinical Oncology. 1996 Feb 1

Journal Articles

• The Prognostic Value of PSA Levels in the Radiation Therapy of Patients with Carinoma of the Prostate: The UCLA Experience 1988-1992.  
  Scott B. Schneider, M.D., Victor G. Schweitzer, M.D., Robert Parker, M.D. and Paul W. Bycott, M.P.H, American Journal of Clin. Oncol. Vol 19, No. 1

Books/Book Chapters

• Cytokines, Cellular & Molecular Therapy, Vol. 5. 
  Chapter: Filgrastim (r-metHuG-CSF) and its potential use in the reduction of radiation-induced oropharyngeal mucositis: An interim look at a randomized, double-blind, placebo controlled trial 
  Page 175 - 180Scott B. Schneider, Russell D. Nishimura, Robert P. Zimmerman, Luu Tran, Josephine Shiplacoff, Marcia Tormey, Richard Contreras and Guy F. Juillard

Abstracts/Posters

• The Prognostic Value of PSA Levels in the Radiation Therapy of Patients with Carinoma of the Prostate: The UCLA Experience 1988-1992.
  Scott B. Schneider, M.D., Victor G. Schweitzer, M.D., Robert Parker, M.D. and Paul W. Bycott, M.P.H, American Association of Cancer Research, Toronto, Canada

Lectures

• The Prognostic Value of PSA Levels in the Radiation Therapy of Patients with Carinoma of the Prostate: The UCLA Experience 1988-1992. 
  Los Angeles, CA, 1994, San Diego, CA, 1996
• Risk of Second Malignancy Based on Treatment Modality in Hodgkin’s Disease. 
  UCLA Resident Seminar, Los Angeles, CA
• Performed assays determining the presence/absence of antibodies to synthetic epitopes of Human Papilloma Virus protein in women with/without known cervical cancer. 
  Stanford University
• G-CSF and Reduction of Radiation Induced Oropharyngeal Mucositis. 
  Los Angeles, CA, 1995, Seoul, Korea, 1996
• Join now to see all